HPV self-testing and cervical cancer screening coverage
A partir d'une revue de la littérature (36 études identifiées, 154 556 participantes), cette étude analyse les résultats d'une recherche du papillomavirus humain lorsque les prélèvements sont réalisés par des cliniciens ou par les femmes elles-mêmes
Over the past decade, much effort has been made to assess the performance of screening assays as alternatives to Pap smear cytology. In the past decade, findings from several randomised trials have shown the superiority of HPV DNA testing using clinician-collected samples compared with Pap testing for the detection of precursor lesions (cervical intraepithelial neoplasia [CIN ] ). In The Lancet Oncology , Marc Arbyn and colleagues present results from a meta-analysis that offer flexibility in the de ...
The Lancet Oncology , commentaire, 2013